Agios Pharmaceuticals, Inc. (AGIO) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
DeepValueTrader DeepValueTrader 06/04/2017 3 months $49.11 $59.18 +20.5% 20 Active
Comments: AGIO's pipeline and licensing deal with CELG are worth $85-$100/sh in 12 months.
stock_crash stock_crash 12/16/2016 1 week $44.18 $41.37 -6.36% -6 Ended
Comments: Hyper Sell Off, Get In Now ... Read the full entry
laurvp laurvp 11/09/2015 1 month $65.04 $52.31 -19.57% 19 Ended
arbo99 arbo99 10/21/2014 1 month $72.90 $93.01 +27.59% 27 Ended
Comments: pipeline potential very promising
alibaba7055 alibaba7055 06/06/2014 1 week $42.79 $44.84 +4.79% 4 Ended
PackerFan PackerFan 06/02/2014 3 months $35.16 $46.22 +31.46% 31 Ended
Comments: Will go back to $42.5
DeepBlueElo DeepBlueElo 03/12/2014 3 months $43.44 $42.62 -1.89% -1 Ended
Comments: Some hype, yes, but AGIO has a unique pipeline, with the highest chances of sucsess in biotech
matrix_man matrix_man 11/07/2013 1 Year $19.99 $83.09 +315.66% 315 Ended
Comments: John LongDoe
itrade001 itrade001 08/20/2013 3 months $26.76 $17.60 -34.23% -34 Ended
Comments: Goldman Sachs analyst Terence Flynn recommended a Buy rating rating and $37.00 price target.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.